Adenoviral vectors for gene delivery in skeletal muscle cells or myoblasts

Details for Australian Patent Application No. 2002212819 (hide)

Owner Crucell Holland B.V.

Inventors Havenga, Menzo Jans Emco; Bout, Abraham

Agent Davies Collison Cave

Pub. Number AU-B-2002212819

PCT Pub. Number WO02/27006

Priority 60235665 26.09.00 US; 00203336 26.09.00 EP

Filing date 25 September 2001

Wipo publication date 8 April 2002

Acceptance publication date 15 March 2007

International Classifications

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

C07K 14/075 (2006.01) Peptides having more than 20 amino acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

15 March 2007 Application Accepted

  Published as AU-B-2002212819

12 July 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002212820

2002212818